Evidence map›Paper›PMID 38438706›Full record

Trial reportJournal of clinical monitoring and computing2024

Predicted effect-site concentrations of remimazolam for i-gel insertion: a prospective randomized controlled study.

Hisako Nishimoto, Tadayoshi Kurita, Mikihiro Shimizu, Koji Morita, Yoshiki Nakajima

Erratum issuedAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Journal of clinical monitoring and computing, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Hisako NishimotoDepartment of Anesthesiology and Intensive Care, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, 431-3192, Japan. 41237099@hama-med.ac.jp.
Tadayoshi KuritaDepartment of Anesthesiology and Intensive Care, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, 431-3192, Japan.
Mikihiro ShimizuCenter for Clinical Research, Hamamatsu University Hospital, 1-20-1 Handayama, Hamamatsu, 431-3192, Japan.
Koji MoritaDepartment of Anesthesiology and Intensive Care, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, 431-3192, Japan.
Yoshiki NakajimaDepartment of Anesthesiology and Intensive Care, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, 431-3192, Japan.
Hamamatsu University School of Medicine · JPHamamatsu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study is the first to report 50% and 95% effect-site concentrations (EC

Indexed as

BenzodiazepinesFentanylAdultAnesthetics, IntravenousDose-Response Relationship, DrugFemaleGelsHumansHypnotics and SedativesMaleMiddle AgedProspective StudiesAnesthetics, IntravenousBenzodiazepinesFentanylGelsHypnotics and SedativesremimazolamDose-responseEffect-site concentrationi-gelRemimazolam

Identifiers

PMID38438706
OpenAlexW4392627061

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.